143 related articles for article (PubMed ID: 29345372)
1. Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.
Spitsin S; Pappa V; Douglas SD
J Leukoc Biol; 2018 Jan; ():. PubMed ID: 29345372
[TBL] [Abstract][Full Text] [Related]
2. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
3. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
4. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
Spitsin S; Stevens KE; Douglas SD
J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
[TBL] [Abstract][Full Text] [Related]
5. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
7. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
8. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
9. Bladder inflammatory transcriptome in response to tachykinins: neurokinin 1 receptor-dependent genes and transcription regulatory elements.
Saban R; Simpson C; Vadigepalli R; Memet S; Dozmorov I; Saban MR
BMC Urol; 2007 May; 7():7. PubMed ID: 17519035
[TBL] [Abstract][Full Text] [Related]
10. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin 1 receptor isoforms and the control of innate immunity.
Tuluc F; Lai JP; Kilpatrick LE; Evans DL; Douglas SD
Trends Immunol; 2009 Jun; 30(6):271-6. PubMed ID: 19427266
[TBL] [Abstract][Full Text] [Related]
12. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
[TBL] [Abstract][Full Text] [Related]
13. Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
Monaco-Shawver L; Schwartz L; Tuluc F; Guo CJ; Lai JP; Gunnam SM; Kilpatrick LE; Banerjee PP; Douglas SD; Orange JS
J Leukoc Biol; 2011 Jan; 89(1):113-25. PubMed ID: 20940324
[TBL] [Abstract][Full Text] [Related]
14. Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Polidoro G; Giancola F; Fracassi F; Pietra M; Bettini G; Asti M; Chiocchetti R
Res Vet Sci; 2017 Oct; 114():297-307. PubMed ID: 28628846
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of substance P and NK1R in blood monocytes and B cells of patients with allergic rhinitis and asthma.
Han P; Chen L; Chen D; Yang R; Wang W; Liu J; He S; Zhang H
Clin Exp Immunol; 2022 Oct; 210(1):39-52. PubMed ID: 36001730
[TBL] [Abstract][Full Text] [Related]
16. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
17. Substance P enhances the local activation of NK
Jeong YM; Cheng XW; Lee KH; Lee S; Cho H; Kim W
BMC Mol Cell Biol; 2020 Jun; 21(1):41. PubMed ID: 32517655
[TBL] [Abstract][Full Text] [Related]
18. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
[TBL] [Abstract][Full Text] [Related]
19. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
20. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
